Ascendis Pharma AS (ASND)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$17.10B
EV to revenue ratio (TTM)
14.01
EV to ebitda
76.92
Financial Performance
Revenue (TTM)
$1.05B
Gross profit (TTM)
$0.96B
EBITDA
$0.26B
Profitability
Operating margin (TTM)
65.00%
Profit margin
70.90%
Return on assets (TTM)
9.58%
Return on equity (TTM)
118.80%
Per Share Metrics
Revenue per share (TTM)
$16.89
EPS
$13.05
Diluted EPS (TTM)
$13.05
Book value
$24.57
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
19.91
Trailing P/E
19.91
Forward P/E
21.79
PEG ratio
n/a
Price to sales ratio (TTM)
16.33
Price to book ratio (TTM)
10.46
Growth
Quarterly earnings growth (YoY)
114.70%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
5
Buy
15
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.49